The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: Q&A on Friday’s press briefs
In this press brief Q&A from ESMO 2016, Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland, Lidija Kandolf-Sekulovic, MD, PhD of the Military Medical Academy, Belgrade, Serbia, Josep Tabernero, MD, PhD of Vall d’Hebron University Hospital, Barcelona, Spain, Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain, Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark and Fortunato Ciardiello, MD, PhD of Second University of Naples, Naples, Italy answer questions from the audience on the press briefs from Friday.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
